FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308206192> ?p ?o ?g. }

• W4308206192 endingPage "531" @default.
• W4308206192 startingPage "523" @default.
• W4308206192 abstract "Patients with recurrent platinum-resistant ovarian cancer often present with inoperable malignant bowel obstruction (MBO) from a large burden of abdominal disease. Interventions such as total parenteral nutrition (TPN) and chemotherapy may be used in this setting. We aim to describe the relative cost-effectiveness of these interventions to inform clinical decision making.Four strategies for management of platinum-resistant recurrent ovarian cancer with inoperable MBO were compared from a societal perspective using a Monte Carlo simulation: (1) hospice, (2) TPN, (3) chemotherapy, and (4) TPN + chemotherapy. Survival, hospitalization rates, end-of-life (EOL) setting, and MBO-related utilities were obtained from literature review: hospice (survival 38 days, 6% hospitalization), chemotherapy (42 days, 29%), TPN (55 days, 25%), TPN + chemotherapy (74 days, 47%). Outcomes were the average cost per strategy and incremental cost-effectiveness ratios (ICERs) in US dollars per quality-adjusted life year (QALY) gained.In the base case scenario, TPN + chemotherapy was the most costly strategy (mean; 95% CI) ($49,741; $49,329-$50,162) and provided the highest QALYs (0.089; 0.089-0.090). The lowest cost strategy was hospice ($14,591; $14,527-$14,654). The TPN alone and chemotherapy alone strategies were dominated by a combination of hospice and TPN + chemotherapy. The ICER of TPN + chemotherapy was $918,538/QALY compared to hospice. With a societal willingness to pay threshold of $150,000/QALY, hospice was the strategy of choice in 71.6% of cases, chemotherapy alone in 28.4%, and TPN-containing strategies in 0%.TPN with or without chemotherapy is not cost-effective in management of inoperable malignant bowel obstruction and platinum-resistant ovarian cancer." @default.
• W4308206192 created "2022-11-09" @default.
• W4308206192 creator A5037901720 @default.
• W4308206192 creator A5043760174 @default.
• W4308206192 creator A5060257138 @default.
• W4308206192 creator A5078057277 @default.
• W4308206192 creator A5083843089 @default.
• W4308206192 creator A5085606987 @default.
• W4308206192 date "2022-12-01" @default.
• W4308206192 modified "2023-10-04" @default.
• W4308206192 title "Cost-effectiveness of management strategies for patients with recurrent ovarian cancer and inoperable malignant bowel obstruction" @default.
• W4308206192 cites W1960327677 @default.
• W4308206192 cites W1975600227 @default.
• W4308206192 cites W1977915223 @default.
• W4308206192 cites W1980349806 @default.
• W4308206192 cites W1992000599 @default.
• W4308206192 cites W1994535265 @default.
• W4308206192 cites W1997710373 @default.
• W4308206192 cites W2001870425 @default.
• W4308206192 cites W2002560580 @default.
• W4308206192 cites W2029630138 @default.
• W4308206192 cites W2057882552 @default.
• W4308206192 cites W2058056848 @default.
• W4308206192 cites W2059193589 @default.
• W4308206192 cites W2086468919 @default.
• W4308206192 cites W2086749703 @default.
• W4308206192 cites W2090859762 @default.
• W4308206192 cites W2105150873 @default.
• W4308206192 cites W2108885472 @default.
• W4308206192 cites W2130533632 @default.
• W4308206192 cites W2217211501 @default.
• W4308206192 cites W2302801691 @default.
• W4308206192 cites W2347154245 @default.
• W4308206192 cites W2561425398 @default.
• W4308206192 cites W2726365305 @default.
• W4308206192 cites W2748355699 @default.
• W4308206192 cites W2803466357 @default.
• W4308206192 cites W2885428556 @default.
• W4308206192 cites W2924985716 @default.
• W4308206192 cites W2996952078 @default.
• W4308206192 cites W3001632091 @default.
• W4308206192 cites W3026585120 @default.
• W4308206192 cites W3047623440 @default.
• W4308206192 cites W3143870538 @default.
• W4308206192 cites W3196382994 @default.
• W4308206192 cites W3207897599 @default.
• W4308206192 doi "https://doi.org/10.1016/j.ygyno.2022.10.013" @default.
• W4308206192 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36344293" @default.
• W4308206192 hasPublicationYear "2022" @default.
• W4308206192 type Work @default.
• W4308206192 citedByCount "2" @default.
• W4308206192 countsByYear W43082061922023 @default.
• W4308206192 crossrefType "journal-article" @default.
• W4308206192 hasAuthorship W4308206192A5037901720 @default.
• W4308206192 hasAuthorship W4308206192A5043760174 @default.
• W4308206192 hasAuthorship W4308206192A5060257138 @default.
• W4308206192 hasAuthorship W4308206192A5078057277 @default.
• W4308206192 hasAuthorship W4308206192A5083843089 @default.
• W4308206192 hasAuthorship W4308206192A5085606987 @default.
• W4308206192 hasConcept C112930515 @default.
• W4308206192 hasConcept C118552586 @default.
• W4308206192 hasConcept C121608353 @default.
• W4308206192 hasConcept C126322002 @default.
• W4308206192 hasConcept C141071460 @default.
• W4308206192 hasConcept C143998085 @default.
• W4308206192 hasConcept C177713679 @default.
• W4308206192 hasConcept C27415008 @default.
• W4308206192 hasConcept C2776694085 @default.
• W4308206192 hasConcept C2779787475 @default.
• W4308206192 hasConcept C2780427987 @default.
• W4308206192 hasConcept C3019080777 @default.
• W4308206192 hasConcept C64332521 @default.
• W4308206192 hasConcept C71924100 @default.
• W4308206192 hasConcept C78722104 @default.
• W4308206192 hasConceptScore W4308206192C112930515 @default.
• W4308206192 hasConceptScore W4308206192C118552586 @default.
• W4308206192 hasConceptScore W4308206192C121608353 @default.
• W4308206192 hasConceptScore W4308206192C126322002 @default.
• W4308206192 hasConceptScore W4308206192C141071460 @default.
• W4308206192 hasConceptScore W4308206192C143998085 @default.
• W4308206192 hasConceptScore W4308206192C177713679 @default.
• W4308206192 hasConceptScore W4308206192C27415008 @default.
• W4308206192 hasConceptScore W4308206192C2776694085 @default.
• W4308206192 hasConceptScore W4308206192C2779787475 @default.
• W4308206192 hasConceptScore W4308206192C2780427987 @default.
• W4308206192 hasConceptScore W4308206192C3019080777 @default.
• W4308206192 hasConceptScore W4308206192C64332521 @default.
• W4308206192 hasConceptScore W4308206192C71924100 @default.
• W4308206192 hasConceptScore W4308206192C78722104 @default.
• W4308206192 hasIssue "3" @default.
• W4308206192 hasLocation W43082061921 @default.
• W4308206192 hasLocation W43082061922 @default.
• W4308206192 hasOpenAccess W4308206192 @default.
• W4308206192 hasPrimaryLocation W43082061921 @default.
• W4308206192 hasRelatedWork W1967715255 @default.
• W4308206192 hasRelatedWork W1982007038 @default.
• W4308206192 hasRelatedWork W2043028331 @default.
• W4308206192 hasRelatedWork W2118496982 @default.

• next